ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,811.80
-0.46%
S&P ASX All Technology
3,103.10
0.92%
Brent Oil
81.145
-0.47%
US Dollar vs AUD
1.50909
-0.12%
Bitcoin
67,814.90
-1.86%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Manhattan Pharmaceuticals (MHA)

  7. Manhattan Pharmaceuticals (MHA) News

MHA

Manhattan Pharmaceuticals (MHA)

Manhattan Pharmaceuticals
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:MHA
DateTimeSourceHeadlineSymbolCompany
20/03/200803:35Edgar (US Regulatory)Manhattan Pharmaceuticals Inc-Amended Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/re.. (25/A)AMEX:MHAManhattan Pharmaceuticals
11/03/200805:14Edgar (US Regulatory)Manhattan Pharmaceuticals Inc-Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/retired sec. (25)AMEX:MHAManhattan Pharmaceuticals
06/03/200808:19Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)AMEX:MHAManhattan Pharmaceuticals
29/02/200806:43Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
14/02/200809:12Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)AMEX:MHAManhattan Pharmaceuticals
07/02/200809:00Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
04/01/200806:56Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
10/12/200723:07Business WireAMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance with Continued Listing StandardsAMEX:MHAManhattan Pharmaceuticals
15/11/200702:00Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:MHAManhattan Pharmaceuticals
04/10/200706:02Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
04/10/200706:02Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
22/09/200704:35Edgar (US Regulatory)Manhattan Pharmaceuticals Inc (Other) (8-K)AMEX:MHAManhattan Pharmaceuticals
10/07/200721:00PR Newswire (US)Manhattan Pharmaceuticals Provides Update on Clinical PipelineAMEX:MHAManhattan Pharmaceuticals
10/07/200706:30PR Newswire (US)Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estroneAMEX:MHAManhattan Pharmaceuticals
27/06/200722:59PR Newswire (US)Manhattan Pharmaceuticals Acquires Hedrin(TM) for the Treatment of Head LiceAMEX:MHAManhattan Pharmaceuticals
10/05/200723:29PR Newswire (US)Manhattan Pharmaceuticals Successfully Completes Dosing Portion of Two Phase 2a Clinical Trials of Oral Oleoyl-estrone for ObesiAMEX:MHAManhattan Pharmaceuticals
04/04/200723:29PR Newswire (US)Manhattan Pharmaceuticals Announces License Agreement and Expanded PipelineAMEX:MHAManhattan Pharmaceuticals
02/04/200723:29PR Newswire (US)Manhattan Pharmaceuticals Completes $8.6 Million Private PlacementAMEX:MHAManhattan Pharmaceuticals
27/03/200723:29PR Newswire (US)AMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance With Continued Listing StandardsAMEX:MHAManhattan Pharmaceuticals
22/02/200700:29PR Newswire (US)Manhattan Pharmaceuticals Completes Enrollment in Phase 2a Study of Oral Oleoyl-estrone for ObesityAMEX:MHAManhattan Pharmaceuticals
09/11/200600:29PR Newswire (US)Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites to USAMEX:MHAManhattan Pharmaceuticals
09/11/200600:29PR Newswire (US)Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites to USAMEX:MHAManhattan Pharmaceuticals
12/10/200623:29PR Newswire (US)Manhattan Pharmaceuticals Expanding Oral Oleoyl-estrone Clinical Program to Include Morbidly ObeseAMEX:MHAManhattan Pharmaceuticals
30/06/200601:29PR Newswire (US)Manhattan Pharmaceuticals Doses First Patient Group In Phase IIa Trial For OE, Its Oral Obesity Drug CandidateAMEX:MHAManhattan Pharmaceuticals
16/05/200623:02PR Newswire (US)Manhattan Pharmaceuticals Receives SwissMedic's Approval to Commence Phase IIa Trial With OE, Its Oral Obesity Drug CandidateAMEX:MHAManhattan Pharmaceuticals
29/12/200503:25PR Newswire (US)Manhattan Pharmaceuticals' Topical Psoriasis Treatment in Phase IIa TrialAMEX:MHAManhattan Pharmaceuticals
08/10/200503:35PR Newswire (US)American Stock Exchange Lists Common Stock of Manhattan Pharmaceutical Inc.AMEX:MHA
 Showing the most relevant articles for your search:AMEX:MHA

Your Recent History

FX
AUDJPY
AUD vs Yen
NYSE
DIS
Walt Disney
ASX
NAB
National Australia Bank
SPI
SP500
S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
AUDUSD
AUD vs US Dollar
ASX
CBA
Commonwealth Bank Of Aus...
ASX
XMM
S&P ASX 300 Metals and M...
ASX
FMG
Fortescue
ASX
XJO
S&P ASX 200
ASX
XFL
S&P ASX 50
ASX
SUN
Suncorp
ASX
AMP
AMP
ASX
XTO
S&P ASX 100
ASX
WPL
Woodside Petroleum
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved